What Is mTOR?

What mTOR is

mTOR stands for the mechanistic target of rapamycin (historically 'mammalian target of rapamycin'). It is a large, highly conserved serine/threonine protein kinase that acts as a central hub for cell growth. Where AMPK is the sensor of energy scarcity, mTOR is the sensor of nutrient and growth-signal abundance — when conditions favor growth, mTOR gives the go-ahead to build proteins, expand the cell, and proliferate.

mTOR was discovered through studies of rapamycin, a compound from a soil bacterium found on Rapa Nui (Easter Island). Rapamycin inhibits mTOR, and tracing how it worked revealed the kinase and its central role in growth control. That origin is why the protein carries 'target of rapamycin' in its name.

mTORC1 and mTORC2: two complexes, two jobs

mTOR does not act alone. It assembles into two distinct multiprotein complexes with different partners, targets, and behaviors. mTOR complex 1 (mTORC1) contains the defining scaffold protein Raptor and is the classic nutrient- and growth-sensing complex — it is also the one acutely inhibited by rapamycin. mTOR complex 2 (mTORC2) contains Rictor, is less sensitive to acute rapamycin, and governs cell survival, the cytoskeleton, and feedback on insulin signaling.

Most of the metabolic and aging discussion centers on mTORC1, because it is the node that directly translates nutrient status into growth decisions. mTORC2 matters too — it phosphorylates Akt and helps close feedback loops with the IGF-1/insulin pathway — but it is less directly tied to nutrient sensing.

How mTORC1 senses and responds

mTORC1 integrates several inputs before deciding to promote growth. Amino acids — especially leucine — signal at the lysosome through the Rag GTPases to recruit mTORC1 to where it can be activated. Growth factors such as insulin and IGF-1 act through the PI3K/Akt pathway, which relieves the inhibitory TSC complex and allows the small GTPase Rheb to switch mTORC1 on. Energy status is layered on top: when energy falls, AMPK inhibits mTORC1 both directly and by activating TSC.

When all signals say 'grow,' active mTORC1 phosphorylates its two best-known effectors: S6 kinase 1 (S6K1) and the translation repressor 4E-BP1. Phosphorylating these ramps up protein synthesis — the cell begins manufacturing the machinery it needs to enlarge and divide. mTORC1 also promotes lipid and nucleotide synthesis, rounding out an overall anabolic, build-and-store program.

Just as important is what mTORC1 turns off. Active mTORC1 suppresses [autophagy](/autophagy-explained) — the cell's recycling and cleanup process — by inhibiting the ULK1 complex. In nutrient-rich conditions this makes sense: there is no need to recycle when raw materials are plentiful. But it means that when mTORC1 is chronically active, autophagy stays low, which is one reason mTOR features so prominently in aging research.

The AMPK seesaw and aging

mTOR is best understood next to its counterweight, [AMPK](/what-is-ampk). AMPK is activated by low energy and pushes the cell toward conservation, recycling, and mitochondrial upgrades; mTOR is activated by abundance and pushes toward growth. The two directly antagonize each other, so a cell is generally tilted toward one program or the other. Interventions like fasting, caloric restriction, and exercise tend to lower mTOR and raise AMPK.

This balance is a recurring theme in longevity science. Inhibiting mTOR with rapamycin extends lifespan in yeast, worms, flies, and mice — one of the more reproducible findings in aging research — largely by enhancing autophagy and reducing chronic growth signaling. The same logic connects mTOR to the growth hormone axis, IGF-1 signaling, and downstream FOXO pathways and sirtuins that shape stress resistance and metabolism. For the broader energy network, see mitochondrial biogenesis and the research library.